Human noroviruses (HuNoV), members of the family Caliciviridae, are the major cause of acute viral gastroenteritis worldwide. Successful infection is linked to the ability of the protruding (P) domain of the viral capsid to bind histo-blood group antigens (HBGA). Binding to gangliosides plays a major role for many nonhuman calici-and noroviruses. Increasing evidence points to a broader role of sialylated carbohydrates such as gangliosides in norovirus infection. Here, we compare HBGA and ganglioside binding of a GII.4 HuNoV variant (MI001), previously shown to be infectious in a HuNoV mouse model. Saturation transfer difference nuclear magnetic resonance spectroscopy, native mass spectrometry (MS) and surface plasmon resonance spectroscopy were used to characterize binding epitopes, affinities, stoichiometry and dynamics, focusing on 3′-sialyllactose, the GM3 ganglioside saccharide and B antigen. Binding was observed for 3′-sialyllactose and various HBGAs following a multistep binding process. Intrinsic affinities (Kd) of fucose, 3′-sialyllactose and B antigen were determined for the individual binding steps. Stronger affinities were observed for B antigen over 3′-sialyllactose and fucose, which bound in the mM range. Binding stoichiometry was analyzed by native MS showing the presence of four B antigens or two 3′-sialyllactose in the complex. Epitope mapping of 3′-sialyllactose revealed direct interaction of α2,3-linked sialic acid with the P domain. The ability of HuNoV to engage multiple carbohydrates emphasizes the multivalent nature of norovirus glycan-specificity. Our findings reveal direct binding of a GII.4 HuNoV P dimer to α2,3-linked sialic acid and support a broader role of ganglioside binding in norovirus infection.
Introduction
Noroviruses, members of the family Caliciviridae, are small (27-40 nm), nonenveloped, icosahedral viruses that possess a singlestranded plus-sense RNA genome (Knipe and Howley 2013) . They are classified as seven genogroups (GI-GVII), subdivided into several genotypes. Only GI, GII and GIV are pathogenic in humans, while viruses from other genogroups only cause disease in animals: GIII in cows, GV in rodents and GVI and GVII in dogs (Vinjé 2015) .
Human noroviruses (HuNoV) are the major cause of sporadic cases and outbreaks of gastroenteritis worldwide. The GII.4 genotype in particular has predominated as a common pandemic strain and constitutes a significant global health concern (Debbink et al. 2013) .
HuNoVs engage various carbohydrate moieties, predominantly histo-blood group antigens (HBGA) (Tan and Jiang 2010) but also heparan sulfate (Tamura et al. 2004) , human milk oligosaccharides (HMO) (Schroten et al. 2016 ) and gangliosides (Han et al. 2014) . So far, only binding to HBGAs has been shown to play a role in infection (Hutson et al. 2002; Lindesmith et al. 2003) . Expression of Fucosyltransferase 2 (FUT2), the genetic determinant for HBGA synthesis and secretor status, has been linked to infection in human volunteer studies (Lindesmith et al. 2003; Frenck et al. 2012) , epidemiologic investigations (Thorven et al. 2005; Tan et al. 2008; Le Guyader et al. 2010; Bustamante et al. 2016) , as well as ex vivo human intestinal enteroids (Ettayebi et al. 2016) .
Little is still known on functional aspects of HuNoV carbohydrate interactions, because tractable platforms to investigate HuNoV infection, such as the B-cell culture system (Jones et al. 2014 ), the mouse model for HuNoV (Taube et al. 2013 ) and the stem-cell derived human intestinal enteroid system (Ettayebi et al. 2016 ) have only recently become available.
Norovirus particles are composed of 90 dimers of the major capsid protein VP1 (Prasad et al. 1999) . Binding to HBGA is mediated by its protruding domain (P domain) (Cao et al. 2007; Bu et al. 2008) . Recombinant expressed P dimers retain antigenicity and carbohydrate-binding capabilities and constitute a valuable tool to study glycan interactions in vitro (Tan et al. 2004) . Multiple crystallography studies revealed the structural bases for HuNoV-HBGA interactions of various strains (Cao et al. 2007; Bu et al. 2008; Choi et al. 2008; Chen et al. 2011; Hansman et al. 2011; Singh et al. 2015) and showed that locations of the GII binding epitopes are generally located within a canyon at the interface of the P domain dimer. A multivalent interaction with four HBGA was shown for the GII.4 SAGA strain (Mallagaray et al. 2015) and X-ray crystallography of the GII.10 Vietnam 026 P domain dimers revealed four fucose binding sites within the canyon (Koromyslova et al. 2015) .
Adapting to specific carbohydrate receptors constitutes a major driving force in HuNoV evolution (Donaldson et al. 2008) . Binding to HBGA and other carbohydrates is highly selective and different variants exhibit distinct binding profiles (Huang et al. 2003; Shanker et al. 2017) . Structural constraints in the binding pocket impact the choice of the carbohydrate ligand (Singh et al. 2016) and not all HuNoV strains bind to HBGA (Huang et al. 2005; Lindesmith et al. 2005) .
Binding to sialylated glycans has been observed for a great number of viruses (Olofsson and Bergström 2005) and gangliosides in particular act as receptors for many nonenveloped viruses (Taube et al. 2010 ). An increasing number of caliciviruses have now been shown to bind to sialylated glycans, including feline calicivirus (FCV) from the Vesivirus genus (Stuart and Brown 2007) , porcine sapovirus (PoSaV) from the Sapovirus genus (Kim et al. 2014) , Tulane virus (TV) from the Recovirus genus and murine noroviruses (MNV) from the Norovirus genus (Taube et al. 2009 (Taube et al. , 2012 . HuNoV also engage sialylated HBGAs, including sialyl Lewis X and sialyl diLewis X (Rydell et al. 2009 ) and although terminal sialic acids by themselves were not sufficient for binding, they were shown to be necessary. Recent data now provide evidence that sialic acid-containing glycosphingolipids (gangliosides) are ligands for GI and GII HuNoV (Han et al. 2014 ).
Results
In this study, we investigate binding of the human GII.4 variant (MI001: Hu/GII.4/MI001/2011/US) to selected fucosylated and sialylated oligosaccharides (summarized in Figure 1 ). Previous analysis showed that MNV bind terminal sialic acids, specifically on gangliosides (Taube et al. 2009 (Taube et al. , 2012 . Since there is now evidence that HuNoV also bind gangliosides, we investigated HBGA and ganglioside binding of MI001, a HuNoV GII.4 strain, previously shown to be infectious in a mouse model (Taube et al. 2013 ).
Binding of the HuNoV (MI001) P dimer to 3′-sialyllactose involves direct interactions with α2,3-linked sialic acid residue STD NMR is ideally suited to study low-affinity protein-ligand interactions in solution Meyer 1999, 2001 ) and has been successfully used to describe various norovirus HBGA interactions in the past (Fiege et al. 2012; Mallagaray et al. 2015 Mallagaray et al. , 2017 . Analysis was performed with 3′-sialyllactose the GM3 trisaccharide (10) (Figure 2 ), galactose (1) (Fig. S3) , as well as free sialic acid (8), and α-sialic acid methyl glycoside (9) (data not shown). Specific STD signals were only detected for 3′-sialyllactose (10, Figure 2 ) but not for the monosaccharides galactose (1, Fig. S3 ) or sialic acid (8,7, not shown). The epitope mapping of 3′-sialyllactose, however, revealed direct interaction with all carbohydrate subunits, including the α2,3-linked sialic acid residue (Figure 2 ). This shows that binding of the P dimer to sialylated carbohydrates requires saccharides larger than monosaccharides for efficient interaction.
One HuNoV (MI001) P dimer can interact with two molecules of 3′-sialyllactose Native mass spectrometry (MS) was performed to investigate the binding stoichiometry of 3′-sialyllactose (10) and MI001 P dimer (Figure 3) . Cytochrome c was used as a nonbinding reference to correct P dimer signals for unspecific clustering (Sun et al. 2006) . As is evident from Figure 3B , more glycans are associated to the P dimer indicating specific binding on top of method-related clustering. Two ligand concentrations (0.1 and 0.25 mM 3′-sialyllactose) were analyzed to determine the maximum number of binding sites to mimic conditions in previous experiments on the SAGA P domain dimer, as well as STD NMR conditions. At the highest ligand concentration, two 3′-sialyllactose molecules were observed in the bound complex after data correction ( Figure 3C) . A third 3′-sialyllactose observed in the raw data is exclusively due to unspecific effects and hence not observed in the corrected data. These data confirm that there are at least two 3′-sialyllactose binding epitopes per MI001 P domain dimer.
SPR titrations reveal a two-step cooperative binding process for 3′-sialyllactose SPR titrations were performed with 3′-sialyllactose (10) to determine the dissociation constant of the interaction (Figure 4) . The SPR response for increasing 3′-sialyllactose (10) concentrations up to 18 mM reveals sigmoidal shaped binding isotherms with a distinct step, indicating cooperativity for the second binding step. This is in agreement with our native MS observations showing two 3′-sialyllactose (10) molecules in the bound complex. Consequently, a cooperative two-step binding model (Mallagaray et al. 2015 ) was used to determine the respective dissociation constants, showing a K d1 of 4.4 mM for the first binding step and a K d2 of 11.5 mM for the second step (see Table I ).
In summary, these data reveal binding of a novel GII.4 strain (MI001) with two 3′-sialyllactose molecules per P domain dimer and direct involvement of all carbohydrate subunits including α2-3-linked sialic acid.
HuNoV (MI001) P dimer binds fucose and type 1 ABH antigens
We further investigated, whether the MI001 strain retains its ability to bind to ABH antigens ( Figure 5 ). For this, STD NMR analysis was performed with fucose (2, Fig S2) , H disaccharide (3, not shown), A trisaccharide (4, not shown) and B trisaccharide (5, Figure 5 ). MI001 P dimer retained binding to all analyzed HBGAs. The epitope mapping of B trisaccharide showed direct interaction with all carbohydrate subunits including the α1,2-linked fucose residue ( Figure 5B and C). Unlike the sialic acid or galactose monosaccharides, the fucose methyl glycoside was sufficient for binding to the P dimer (Figs. S2 and S3).
One HuNoV (MI001) P dimer can interact with two molecules A antigen or four molecules B antigen
Native MS was performed to further investigate the stoichiometry of HBGA binding (Figures 6 and 7) . Here, higher mass A or B tetrasaccharides (6, 7) were used to obtain better peak resolution. Two ligand concentrations (0.1 and 0.25 mM) were investigated for each glycan in separate experiments and again cytochrome c was used as a reference for clustering. After correction, our results reveal two molecules of the A antigen ( Figure 6B ) or four molecules of B antigen ( Figure 7B ) in the complexes. These data confirm binding of MI001 P domain dimer to HBGA and further postulate the presence of two additional HBGA binding sites with a preference for B antigen.
B antigen titrations reveal a four-step cooperative binding process
To determine the dissociation constants of the respective interactions, STD NMR titrations were performed with increasing B trisaccharide (5) concentrations (up to 8 mM, Figure 8 ) and increasing fucose (2) concentrations (up to 20 mM, data not shown). Only residual direct irradiation over the ligands was observed within these ranges. Monitoring STD NMR signals for B antigen (5) reveals sigmoidal shaped binding isotherms with three distinct steps, again indicating cooperativity (Figure 8 ). We therefore used a binding model for successive cooperative binding events as previously described (Mallagaray et al. 2015) and determined the apparent dissociation constants K d1 -K d4 for each respective binding event. B antigen (5) titration resulted in K d values ranging between 40 μM for K d1 and 5.1 mM for K d4 , while fucose (2) titrations revealed only two binding events with K d values: 2.9 mM for K d1 and 12.2 mM for K d2 . Based on the first binding event, the larger B trisaccharide (5) showed an approximately 2-log stronger interaction compared to fucose (2) or 3′-sialyllactose (10) (summarized in Table I ).
In summary, these data show that MI001 interacts with all analyzed ABH antigens and that although larger oligosaccharides may not be necessary for binding, they greatly improve affinity of the ligand compared to the monosaccharide. 
Discussion
This is the first report comparing affinity and stoichiometry of HBGA and 3′-sialyllactose with HuNoV. We further describe the first direct interaction of HuNoV P domain with α2,3-linked sialic acid. Although the importance of sialic acids is well known for a variety of viruses (Taube et al. 2010; Stencel-Baerenwald et al. 2014) , only few studies examined the role of sialylated carbohydrates in HuNoV infection (Rydell et al. 2009; Han et al. 2014 ). An increasing number of caliciviruses are now being identified to specifically bind sialylated glycans, including FCV (Stuart and Brown 2007) , MNV (Taube et al. 2009 (Taube et al. , 2012 , PoSaV (Kim et al. 2014) and TV . Some of these viruses also recognize sialylated glycans in addition to HBGAs, such as TV, PoSaV and now HuNoV (Rydell et al. 2009; Han et al. 2014) .
Our STD NMR analysis confirms binding to the soluble saccharide of GM3 (3′-sialyllactose), using a recombinant P domain dimer derived from a HuNoV GII.4 strain infectious in a mouse model for HuNoV infection. The epitope mapping revealed that all three saccharide units from 3′-sialyllactose, including the α2,3-linked sialic acid, are directly involved in the interaction. However, binding was only observed for the 3′-sialyllactose but not for the analyzed monosaccharides of sialic acid and galactose. This corroborates previous findings for sialylated HBGAs, showing that terminal sialic acid itself is not sufficient for binding to sialylated glycans (Rydell et al. 2009 ) but is recognized when present in larger oligosaccharides.
Native MS showed two 3′-sialyllactose molecules in the bound complex, suggesting a similar binding stoichiometry as observed for H and A antigens. STD NMR-based titrations were performed but direct ligand irradiation was observed at 10 mM ligand concentration, possibly due to ligand aggregation, precluding the observation of the second binding event (data not shown). We therefore performed SPR titrations, which revealed two successive cooperative binding events, which support our native MS data. Apparent dissociation constants of the individual binding steps were determined and the affinity of 3′-sialyllactose's first binding step (K d1 4.4 mM) was comparable to that of fucose (K d1 2.9 mM) but 2-logs weaker than B antigen (K d1 40 μM). This is in contrast to observations by Han et al., who also investigated binding to a GII.4 (VA387) P domain but observed a ca. 2-fold stronger interaction with 3′-sialyllactose (K a, int : 1500 M -1 ≃ K d 0.7 mM) (Han et al. 2014 ), compared to a B trisaccharide (K a, int : 800 M -1 ≃ K d 1.25 mM) (Han et al. 2013 (Han et al. , 2015 . These differences may reflect properties of the different GII.4 strains used (MI001 vs. VA387) but could also be due to differences in the applied methods. While these findings do not give direct information about the biological importance of ganglioside binding in HuNoV infection, they point to a broader role of sialylated carbohydrates, particularly gangliosides, in HuNoV infections.
Variations in carbohydrate specificity can occur at strain level and not all HuNoV bind HBGAs (Huang et al. 2005; Lindesmith et al. 2005) . We therefore investigated, whether our mouse-infectious MI001 strain still recognizes HBGAs. STD NMR analysis confirmed that our MI001 P domain dimer binds type 1 HBGAs. Titration analysis revealed a four-step binding process for B antigen (5) and native MS confirmed the presence of four B antigen molecules in the bound complex. This recapitulates similar findings for the related GII.4 SAGA strain (Mallagaray et al. 2015) . In comparison, protein sequence of the P domains (amino acids 225-530) of GII.4 SAGA and MI001 are 92% identical and putative residues in the described GII.4 HBGA binding sites are also the same. The observed dissociation constants for fucose and B antigen are within error range and slight differences between the Hill coefficients could be explained by different allosteric regulation.
These data underline the presence of two unknown HBGA binding sites in MI001 and SAGA. MS analysis however, did not reveal additional A antigen in the complex. Minor traces of P domain tetramers only detectable by native MS showed no measurable involvement in glycan binding. These data suggest a preference of B over A antigen for these novel binding sites.
Evidence for additional HBGA binding sites in related GII strains comes from X-ray crystallography data, showing that at high concentrations, four fucose molecules can be detected at the interface region of a GII.10 P domain dimer (Koromyslova et al. 2015) .
Further investigations are now needed to determine, whether the additional B antigen binding sites are restricted to MI001 and SAGA or a general feature of GII strains.
Our epitope mapping for the B antigen also revealed multiple protons from the fucose residue and some from the side galactose directly involved in the protein-ligand recognition event. However, unlike the sialic acid methyl glycoside, the fucose methyl glycoside was able to bind by itself, suggesting a broader acceptance for fucosylated carbohydrates.
In the case of HBGA and fucose, we observed a ∼70-fold increase in the affinity of the first binding event of the oligosaccharide compared to the monosaccharide, and a ∼2-log higher affinity of the B antigen compared to 3′-sialyllactose. On a cellular level, lower affinities, as observed for the monosaccharides could be compensated by the multivalent nature of the interaction of the viral particle. Due to this increased avidity, low-affinity interactions may become biologically relevant.
In conclusion, our findings show that the MI001 GII.4P domain binds multiple sialylated and fucosylated glycans. Further investigations are needed to address a possible functional role of sialylated carbohydrates such as gangliosides in HuNoV infection. 
Materials and methods

Carbohydrates
Carbohydrates used in this study (summarized in Figure 1 ) were dissolved in D 2 O for NMR analysis and in H 2 O for SPR and native MS analysis. All carbohydrates were purchased from ElicitylOligotech, except for D-Gal (1) (Merck), A trisaccharide (4) (Carbosynth), H disaccharide (3) (in house synthesis) (Rademacher et al. 2008 ) and Neu5Ac (8) (Dextra).
Recombinant expression and purification of MI001 P dimers P domain (amino acids 225-530, 34.15 kDa) from the GII.4 MI001 variant (Hu/GII.4/MI001/2011/USA, GenBank: KC631814) was expressed as a fusion protein in Escherichia coli (83.6 kDa), N-terminally tagged with a maltose binding protein (MBP), 8× HIS and an HRV3C cleavage site (Hansman et al. 2011) . The codon optimized P domain was cloned downstream of the expression vector pMal-c2X and transformed into E. coli BL21 DE3. Transformed bacteria were cultured at 37°C in terrific broth medium supplemented with 100 μg/mL ampicillin up to an OD 600 nm of 1. Expression was induced with 0.1 mM isopropyl β-D-thiogalactopyranoside and incubated for 18 h at 18°C. Bacteria were harvested by centrifugation (15 min, 4°C, 6000 × g). The pellet was resuspended in ice-cold lysis buffer (25 mM sodium phosphate, 500 mM NaCl pH 7.4) and lysed at 100 MPa pressure in an LM10 Microfluidizer (Microfluidics). The lysate was clarified (30 min, 4°C, 34,500 × g) and filtered through a 0.45 μm filter. The fusion protein was purified by fast protein liquid chromatography (FPLC) on a HisTrap FF column (GE) using an Aekta Purifier (Pharmacia). After three column washes with wash buffer (25 mM sodium phosphate, 500 mM NaCl, 30 mM imidazole pH 7.4), the fusion protein was eluted with elution buffer (25 mM sodium phosphate, 500 mM NaCl, 500 mM imidazole pH 7.4). The purified fusion protein was dialyzed twice against 10 volumes of lysis buffer. After dialysis, the fusion protein was cleaved using the HRV 3C protease (Millipore) for 3 h at room temperature. The MBP and the HRV 3C protease were removed on a HisTrap FF column and the cleaved P domain was harvested in the flowthrough. Further purification was performed using gel filtration on a Superose 12 10/300 column with 25 mM sodium phosphate pH 6.0. P dimer formation was controlled by dynamic light scattering (DLS) and native MS and purity by SDS-PAGE and Western blot (Fig. S1 ).
Sample preparation for NMR spectroscopy
For STD NMR measurements, protein buffer was changed to NMR buffer (25 mM Tris d11 , 300 mM NaCl pH 7.4 in D 2 O or 20 mM sodium phosphate pH 7.3 in D 2 O) using Amicon Ultra-4 10 kDa (Millipore) centrifugal filter devices. All STD experiments were performed using 13-30 μM P domain. The carbohydrate concentration was 2 mM for H disaccharide (3), A trisaccharide (4), B trisaccharide (5), 3′-sialyllactose (10), 4 mM for fucose (2), galactose (1) 
STD NMR experiments
The NMR spectra were recorded on a Bruker AV I 700 MHz NMR spectrometer equipped with a TXI cryogenic probe or on a Bruker AV III 500 MHz NMR spectrometer equipped with a TCI cryogenic probe at 298 K. A pseudo-2D setup with interleaved acquisition of on-and off-resonance spectra with an interscan-delay of 6 s was used, and −4 and 200 ppm were selected as on and off resonances, respectively. Protein irradiation was performed with a train of 50 ms Gaussian-shaped radio frequency pulses separated by 1 ms for a total duration of 2 s and 4 s for 3′-sialyllactose and a power level of 40 dB. Water suppression was done using an excitation sculpting sequence with gradients and the unwanted protein signals were suppressed via a 30 ms spinlock. The acquisition time was set at 2.34 s with a relaxation delay of 4 s for the A trisaccharide (4) and 6 s for the other carbohydrates. For the titrations, the number of scans ranged from 400 to 4000 for fucose (2) and Relative difference responses (RU) at the end of the injections were monitored and plotted against the injected 3′-sialyllactose concentration. Using nonlinear squares fitting Eq. (2), two microscopic dissociation constants (K d1 4.4 mM and K d2 11.5 mM) were determined. Dashed lines depict the extrapolated curves for each binding event. The error bar of each point reflects the standard deviation of the double measurement. Table I . Dissociation constants K di and Hill coefficients (h i ) obtained from STD NMR and SPR titrations using the modified Hill equation (Eq. (2))
B trisaccharide (5) 0.04 ± 0.03 1.0 ± 0.1 1.6 ± 0.3 5.1 ± 0.3 6.5 ± 3.4 16.0 ± 8.4 3.9 ± 0.5 6.0 × 10
GM3 trisaccharide "3′-sialyllactose" (10) 4.4 ± 0.7 11.5 ± 0.2 n.d. n.d. 24.6 ± 5.5 2.7 × 10 −1 n.d., not detected. from 160 to 2600 for B trisaccharide (5). For the epitope mapping, 800 scans were acquired for the B trisaccharide (7) and 3600 for 3′-sialyllactose (10). All experiments were acquired at 298 K. Spectra were analyzed using Topspin 3.1 (Bruker).
Signal assignment
NMR assignment of the carbohydrates was performed using standard pulse sequences from the Bruker library and reported assignments (Sabesan et al. 1991; Fiege et al. 2012; Mallagaray et al. 2015) .
K d determination by STD NMR
Well resolved and assigned signals were used to calculate the STD amplification factor (STD AF) (Mayer and Meyer 1999) :
Being I 0 the off-resonance and I sat the on-resonance intensities. Resulting STD AF were plotted against carbohydrate concentrations and fitted to a multistep cooperative binding model (Mallagaray et al. 2015) :
Being O the observed parameter changing upon titration, in this case STD AF. K di represents the microscopic dissociation constants for the individual binding events, h i the respective Hill coefficient, STD AF max,i the threshold value and n the number of individual binding sites. In case of fucose (2), the difference between total ligand concentration [L] tot and free ligand concentration [L] free was negligible and therefore no correction was required. However, in the case of the B trisaccharide (5) the approximation [L] free = [L] tot becomes invalid for the first two binding events, where low ligand to protein ratios are studied. To correct for this we have employed the law of mass action to calculate the actual values of [L] for the first two steps as described previously (Arai et al. 2012) .
SPR experiments
A Biacore sensor chip CM5 (GE Healthcare) providing a 100 nm carboxy-methylated dextran matrix was covered with MI001 P dimer using the amine coupling method. For this, the sensor chip was docked and primed with running buffer (25 mM sodium phosphate at pH 7.2, 10 mM NaCl and 0.01% sodium azide). The chip surface was normalized using 70% glycerol as described in the Biacore user manual. Following equilibration with running buffer, the carboxy-methylated surface was activated by injection of 120 μL of freshly prepared mixture of 50 mM N-Hydroxysuccinimide (NHS) and 200 mM 1-Ethyl-3-(3-dimethyl-aminopropyl)-carbodiimide (EDC) at flow rate of 10 μL/min. In order to immobilize the protein, a solution of~6 mg/mL MI001 P dimer was diluted in 10 mM sodium acetate to reach a final concentration of~500 μg/mL and a final pH of 4.9. Immobilization was conducted at a flow rate of 5 μL/min with several injections of 5-15 μL until intended response level was reached (~3600 RU). Remaining activated groups were deactivated by injection of 120 μL of 1 M ethanolamine (pH 8.5) at flow rate of 10 μL/min. The reference flow cell was only activated and deactivated. To analyze the binding behavior of the 3′-sialyllactose to immobilized MI001 P dimers, a 40 mM solution of 3′-sialyllactose was prepared in running buffer (pH adjusted) and injected for 2 min at varying concentration at a flow rate of 5 μL/min. The relative difference responses (RU) at the end of the injections were monitored and plotted against the injected analyte concentration. To each data point 3.0 RU were added, including the negative response of 2.4 RU when injecting only running buffer and the baseline drift of 0.6 RU. Data was fitted to Eq. (2) with O being RU and n = 2.
Mass spectrometry
For native MS A type 1 tetrasaccharide (6), B type 1 tetrasaccharide (7) and 3′-sialyllactose (10) were used at indicated concentrations with 4-4.5 μM purified MI001 P dimer and 16-18 μM of the reference protein cytochrome c (Sigma-Aldrich), as described previously (Sun et al. 2006; Han et al. 2013; Mallagaray et al. 2015) . Purified proteins were buffer exchanged prior to MS analysis to 50 mM ammonium acetate (Sigma-Aldrich) at pH 7.5, via centrifugal filter units at 15,000 × g (Vivaspin 500, MWCO 10,000, Sartorius). Native mass spectra were measured at 25°C on a (Q-ToF 2 or LCT) (ESI-ToF) instrument (Waters, UK and MS Vision, the Netherlands) modified for high mass experiments with a nano-electrospray ionization (ESI) source in positive ion mode (van den Heuvel 2006), as previously described (Mallagaray et al. 2015) . Samples were directly infused from gold-coated electrospray capillaries without any accessory chromatographic separation. The voltages and pressures were optimized for noncovalent protein complexes (Tahallah et al. 2001 ). The gas pressures were 10 mbar in the source region and 1.8 × 10
−2 mbar argon in the collision cell. The LCT was operated at a source pressure between 6 and 7 mbar. Measurements were performed under 6.5 × 10 −2 mbar to 6.9 × 10 −2 mbar argon flow in the hexapole. Mass spectra were recorded with applied voltages for the capillary, cone and collision of 1.25-1.35 kV, 150 V and 10 V, respectively, optimized for minimal complex dissociation. For the calibration of the raw data MassLynx software (Waters) and a 25 mg/mL cesium iodide spectrum from the same day was used. MassLynx was used to assign peak series to protein species and to determine the mass after minimal smoothing. Furthermore, the OriginPro 2016 SR2 (OriginLab) software was used for curve A B fitting. Correction for nonspecific protein-ligand clustering was performed with cytochrome c as described (Sun et al. 2006) . Corrected signal intensities were summed over all charge states, normalized to the free protein signal and averaged over at least three independent measurements.
Supplementary data
Supplementary data are available at Glycobiology online. 
